‘POPE’: Predicting outcome by plaque evaluation

J. Narula
DOI: https://doi.org/10.1097/00006231-200007000-00001
2000-07-01
Nuclear Medicine Communications
Abstract:Radionuclide imaging of atherosclerotic lesions is expected to target one of the three major components of plaque ± lipid cores, macrophage infiltration or proliferating smooth muscle cells [1]. Since predominance of any one component determines the behaviour of the plaque, it is logical to assume that detection of abundance of a given component will address the prognostic outcome of the plaque [1]. The presence of large necrotic lipid cores contributes to vulnerability of plaque to rupture. In addition, intense macrophage infiltration of the plaque leads to release of cytokines and matrix metalloproteinases and thereby renders the plaque prone to rupture. On the other hand, prevalence of smooth muscle cells provides stability to the plaque, but rapid proliferation is associated with rapidly progressive luminal stenosis such as in post-angioplastic restenosis. It is possible to selectively target any one of the histological components by radionuclide imaging.
What problem does this paper attempt to address?